Michael Wang1,2, Nafiseh Janaki3, Christina Buzzy1,2, Laura Bukavina1, Amr Mahran1,2, Kirtishri Mishra1, Gregory MacLennan3, Lee Ponsky4,5. 1. Division of Urologic Oncology, Urology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Cleveland, OH, 44106, USA. 2. Case Western Reserve University School of Medicine, Cleveland, OH, USA. 3. Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. 4. Division of Urologic Oncology, Urology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Cleveland, OH, 44106, USA. Lee.Ponsky@UHhospitals.org. 5. Case Western Reserve University School of Medicine, Cleveland, OH, USA. Lee.Ponsky@UHhospitals.org.
Abstract
BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) is increasingly used in detection and surveillance of prostate cancer. However, the co-localization of lower grade lesions between mpMRI and histopathologic specimen has not been well established. OBJECTIVE: We aim to determine the factors on final histopathological exam that correlate to tumor visibility for Grade I and II disease on mpMRI. METHODS: Fifty-five patients who underwent radical prostatectomy from July 2014 to June 2016 were analyzed for the study. Of the sample of 55 patients, 18 were found to have Gleason score (GS) of 3 + 3 or 3 + 4 disease, and then were re-reviewed and annotated by a pathologist. Lesion diameter, area, and distance from the prostate capsule were measured. The annotated lesions were co-localized to the MRI report. RESULTS: Of the 184 lesions identified on the whole mount histopathologic slides, 106 (57.6%), 62 (33.7%), 14 (7.6%), and 2 (1.1%) of the lesions had a GS of 3 + 3, 3 + 4, 4 + 3, and 4 + 4, respectively. On analysis, 27.3% (24/88) of GS 6 (< 1.5 cm in size), and 88.9% (16/18) of GS 6 (> 1.5 cm in size) were identified (p < 0.001). Additionally, when assessing lesion proximity to the prostatic capsule, 46.1% (41/89) of lesions closer (≤ 0.05 cm), and 30.5% (29/95) of lesions further (> 0.05 cm) from the capsule were visualized. CONCLUSION: Lesion diameter, area, and capsule proximity correlated with MRI visibility. Further studies are encouraged to validate the findings of our study.
BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) is increasingly used in detection and surveillance of prostate cancer. However, the co-localization of lower grade lesions between mpMRI and histopathologic specimen has not been well established. OBJECTIVE: We aim to determine the factors on final histopathological exam that correlate to tumor visibility for Grade I and II disease on mpMRI. METHODS: Fifty-five patients who underwent radical prostatectomy from July 2014 to June 2016 were analyzed for the study. Of the sample of 55 patients, 18 were found to have Gleason score (GS) of 3 + 3 or 3 + 4 disease, and then were re-reviewed and annotated by a pathologist. Lesion diameter, area, and distance from the prostate capsule were measured. The annotated lesions were co-localized to the MRI report. RESULTS: Of the 184 lesions identified on the whole mount histopathologic slides, 106 (57.6%), 62 (33.7%), 14 (7.6%), and 2 (1.1%) of the lesions had a GS of 3 + 3, 3 + 4, 4 + 3, and 4 + 4, respectively. On analysis, 27.3% (24/88) of GS 6 (< 1.5 cm in size), and 88.9% (16/18) of GS 6 (> 1.5 cm in size) were identified (p < 0.001). Additionally, when assessing lesion proximity to the prostatic capsule, 46.1% (41/89) of lesions closer (≤ 0.05 cm), and 30.5% (29/95) of lesions further (> 0.05 cm) from the capsule were visualized. CONCLUSION: Lesion diameter, area, and capsule proximity correlated with MRI visibility. Further studies are encouraged to validate the findings of our study.
Entities:
Keywords:
Histopathology; Intermediate prostate cancer; Multiparametric MRI; Prostate cancer
Authors: Amr Mahran; Kirtishri Mishra; Laura Bukavina; Fredrick Schumacher; Anna Quian; Christina Buzzy; Carvell T Nguyen; Vikas Gulani; Lee E Ponsky Journal: Int Urol Nephrol Date: 2019-05-02 Impact factor: 2.370
Authors: David R Rutkowski; Shane A Wells; Brian Johnson; Wei Huang; David F Jarrard; Joshua M Lang; Steve Cho; Alejandro Roldán-Alzate Journal: Am J Clin Exp Urol Date: 2019-08-15
Authors: Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena Journal: Nat Rev Urol Date: 2021-10-19 Impact factor: 14.432